NCT04566393
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04566393 |
| Title | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies |
| Recruitment | Available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | Yes |
| Sponsors | xCures |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | USA |
CKB BOOST